Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib-Reference-Cited by-同舟云学术

Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib

Published:2017-07-24 Issue:5 Volume:182 Page:712-714
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Andrick Benjamin¹²^ORCID,Alwhaibi Abdulrahman²,DeRemer David L.¹²³,Quershi Sameera³,Khan Rahil³,Bryan Locke J.¹³⁴,Somanath Payaningal R.²³⁵,Pantin Jeremy¹³⁴^ORCID

Affiliation:

1. Augusta University (AU) Medical Center; Augusta GA USA

2. Clinical and Experimental Therapeutics; University of Georgia College of Pharmacy; Augusta GA USA

3. Georgia Cancer Center; Augusta GA USA

4. Division of Hematology/Oncology; Augusta University; Augusta GA USA

5. Charlie Norwood VA Medical Center; Augusta GA USA

Funder

University of Georgia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14855/fullpdf

Reference10 articles.

1. Bruton's Tyrosine Kinase is involved in innate and adaptive immunity;Brunner;Histology and Histopathology,2005

2. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia;Byrd;New England Journal of Medicine,2014

3. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention;MMWR. Morbidity and Mortality Weekly Report,2012

4. HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells;Claudio;Oncogene,2001

5. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial;Farooqui;The Lancet. Oncology,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccinations in patients with chronic lymphocytic leukemia;Seminars in Hematology;2024-01

2. Impfungen in der Hämatologie und Onkologie;best practice onkologie;2023-10

3. Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia;Vaccines;2023-07-04

4. Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2;Blood Reviews;2023-07

5. Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia;Vaccine;2023-05